Goswami S

ORCID: 0000-0001-6168-2138 · 4 papers in corpus
lab-animal 2022
Journal of cell science ·doi:10.1242/jcs.259617

We have previously demonstrated significant upregulation of dopamine D2 (DAD2) receptor (DRD2) expression on tumor endothelial cells. The dopamine D2 receptors, upon activation, inhibit the proangiogenic actions of vascular endothelial grow…

review 2016
Oncotarget ·doi:10.18632/oncotarget.8658

Osteoprotegerin (OPG) is a soluble decoy receptor for tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL). It belongs to the tumor necrosis factor receptor superfamily (TNFRSF). OPG was initially discovered to contribute t…

lab-animal 2015
BMC cancer ·doi:10.1186/s12885-015-1837-1

BACKGROUND: Osteoprotegerin (OPG) is a glycoprotein that has multifaceted role and is associated with several cancer malignancies like that of bladder carcinoma, gastric carcinoma, prostate cancer, multiple myeloma and breast cancer. Also O…

rct 2011
Journal of obstetrics and gynaecology of India ·doi:10.1007/s13224-011-0076-x

OBJECTIVE: We designed this study to focus on women with mobile uteri benign no larger than 14 weeks, who would ordinarily be considered candidates for vaginal hysterectomy and compare the outcomes when abdominal routes were chosen. We also…